Recent evidence showed that miRNA-100 downregulates Polo-like kinase 1 in basal-like cancer, blocking the maintenance and expansion of breast cancer stem cells (BrCSCs), inducing BrCSC differentiation, thus favoring the transition from undifferentiated tumors into well-differentiated ones [31,32]. This evidence concerns the gene PLK1 and cancer.